findings, we were interested in examining whether methylation of specific CpG sites is 67 associated with expression of non-nearby cis-genes. We thus conducted an expression 68 quantitative trait methylation (eQTM) analysis in nasal airway epithelium from 455 Puerto 69
Abstract
Nasal airway epithelial methylation profiles have been associated with asthma, but the effects of 23 such profiles on expression of distant cis-genes are largely unknown. We identified 16,867 24 significant methylation-gene expression pairs in nasal epithelium from Puerto Rican children and 25 adolescents (with and without asthma) in an expression quantitative trait methylation (eQTM) 26 analysis of cis-genes located within 1 Mb of the methylation probes tested. Most eQTM 27 methylation probes were distant from their target genes, and more likely located in enhancer 28 regions of their target genes in lung tissue than control probes. The top 500 eQTM genes were 29 enriched in pathways for immune processes and epithelial integrity, and also more likely to be 30 differentially expressed in atopic asthma. Moreover, we identified 5,934 paths through which 31 methylation probes could affect atopic asthma through gene expression. Our findings suggest 32 that distant epigenetic regulation of gene expression in airway epithelium plays a role in atopic 33
asthma. 34
Introduction 44 Asthma is affected not only by genetic variants but also by environmental factors such as 45 second-hand smoke. Since DNA methylation is determined by both genetics and environment, 46 studying methylation in relevant tissues may be key to understanding asthma pathogenesis. 47 48 A growing body of evidence suggests that abnormalities in airway epithelial integrity and 49 function leads to interactions between injurious agents (such as pollutants and viruses) and 50 dendritic cells, altered immune responses, and -ultimately-asthma. DNA methylation and gene 51 expression in nasal (airway) epithelium are well correlated with those in bronchial (airway) 52 epithelium 1 . 53 54 Because bronchial epithelial sampling requires a bronchoscopy (an invasive and costly procedure 55 with non-trivial risks), nasal epithelial sampling is an attractive and safe approach for studies of 56 the airway epithelium and childhood asthma 1 . Indeed, a few epigenome-wide association studies 57 (EWAS) have identified links between DNA methylation in nasal airway epithelium and asthma. 58
For example, we reported 7,104 CpGs associated with atopic (allergic) asthma in Puerto Ricans, 59 an ethnic group disproportionately affected with this disease 2 . 60 61 In our prior EWAS, we estimated the effect of CpGs associated with atopic asthma on the 62 expression of nearby genes (i.e. those adjacent to or containing a CpG of interest) 2 . More 63 recently, we showed that most single nucleotide polymorphisms (SNPs) associated with asthma 64 in a large meta-analysis of genome-wide association studies (GWAS) are not associated with 65 expression of nearby genes, but rather that of more distant cis-genes within 1 Mb. Given such 66 genes associated with atopic asthma mediate the association between methylation and atopic 134 asthma (Figure 4d) . 135 136 eQTM results in EVA-PR are replicated in an African American cohort. 137
To attempt replication of our eQTM results in EVA-PR, we used public data from GSE65205 12 , 138 which includes both methylation and gene expression array data in nasal epithelium for 69 139 children (36 with atopic asthma and 33 healthy controls, mostly [91.3%] African American). 140
Using a similar approach to that used in EVA-PR, this replication eQTM analysis was adjusted 141 for age, sex, race/ethnicity, atopic asthma status, and unobserved batch effects. 142
143
Of the 16,867 significant associations between methylation and gene expression in EVA-PR, we 144 were able to test 14,397 associations in GSE65205, due to differences in the platforms used to 145 assess gene expression (RNA-Seq vs. microarray). Of these 14,397 methylation-expression pairs, 146 12,559 (87.2 %) had the same direction of association in GSE65205. Despite the small sample 147 size of GSE65205, 6,562 (45.6%) of the significant associations in EVA-PR were replicated at 148 FDR-P < 0.05, in the same direction of association ( Table 5 ). These replicated associations 149 include 3,992 methylation probes and 1,106 genes. Of the 3,992 replicated methylation probes, 150
3,222 probes were tested in our prior EWAS in EVA-PR 2 : 1,412 (43.8%) of these 3,222 probes 151 are significantly associated with atopic asthma (FDR-P < 0.05) ( To date, there have been much fewer eQTM studies than eQTL studies 13 , despite probable large 155 joint causal effects of DNA methylation and gene expression on complex diseases. While 156 genotype does not change as a disease progresses, both epigenetic regulation and transcriptomic 157 activity change as a disease develops or worsens. Thus, studying eQTM may complement 158 findings from genetic or eQTL studies and add novel insights into disease pathogenesis. 159
160
Most previous genome-wide eQTM studies have been limited to healthy subjects 14, 15 . In the few 161 instances in which both subjects with asthma and healthy controls were included, only CpGs that 162 were significant in an EWAS -and only genes nearby those CpGs (e.g., within 10 kb)-were 163 examined [16] [17] [18] . In contrast, we assessed all genome-wide CpGs along with expression of cis-164 genes located within 1 Mb in the current analysis of children and adolescents with and without 165 asthma. Moreover, we were able to replicate nearly half of our significant findings in an 166 independent cohort of predominantly African American children. 167
168
Notably, in our analysis most significant eQTM methylation probes were not nearby their target 169 cis-genes, a finding that may be explained by physical contact between CpG sites and 170 promoter/coding regions of distant target genes through looping chromatin structures 19 . 171
Significant eQTM probes were also more likely to be localized in enhancer regions of their target 172 genes in lung tissue than control probes, suggesting that CpG sites can affect transcription of 173 non-nearby (distant) cis-genes through enhancer activity. We also found that while most 174 methylation probes near TSS were negatively correlated with gene expression, more distant pairs 175 tended to be positively correlated. Consistent with our findings, methylation in promoter regions 176 and the first intron have been negatively correlated with gene expression, while methylation of 177 more distant CpG sites and gene expression has been positively correlated with gene expression 178 in several types of cancer 20,21 22 . 179 We show an over-representation of the top eQTM methylation probes among CpGs associated 180 with atopic asthma. Similarly, we report an over-representation of the top eQTM genes among 181 DEG in atopic asthma. Moreover, we show that most associations between eQTM methylation 182 probes and atopic asthma are mediated by gene expression. Given that we also found that eQTM 183 methylation probes in nasal epithelium are over-represented in enhancer regions of their paired 184 genes in lung tissue, our findings provide further support for studies of nasal epithelial 185 epigenomics and transcriptomics as a valid alternative to more invasive and costly studies of 186 bronchial epithelium. 187
188
We recognize several study limitations. First, we only included subjects in a high-risk population 189 (Puerto Ricans). However, we have previously replicated findings from GWAS 9 In summary, we identified significant methylation-expression pairs in an eQTM analysis of nasal 198 airway epithelium of subjects with and without asthma. Most methylation probes were associated 199 with expression of distant cis-genes, and eQTM genes were enriched in immune regulation and 200 epithelial integrity. Moreover, eQTM methylation probes and eQTM genes were over-201
represented among those associated with atopic asthma, further suggesting a key role of 202 epigenetic regulation of gene expression in airway epithelium in disease pathogenesis. 203
Methods

204
Study population 205
Subject recruitment and study procedures for the Epigenetic Variation and Childhood Asthma in 206
Puerto Ricans (EVA-PR) have been previously described 2 . In brief, EVA-PR is a case-control 207 study of asthma in subjects aged 9-20 years. Participants with and without asthma were recruited 208 from households in San Juan (PR) from February 2014 through May 2017, using multistage 209 probability sampling; 638 households had ≥1 eligible subject, and 543 (85.1%) subjects (one per 210 household) agreed to participate. There were no significant differences in age or sex between 211 eligible children who did and did not participate. BeadChips (Illumina), as previously described 2 . Beta-values, ranging from 0 to 1, were 230 calculated to measure percentage methylation at each CpG site. We then transformed beta values 231
to M values because M values are closer to having a normal distribution (for linear regression 232 analysis). As previously described, RNASeq was conducted with the Illumina NextSeq 500 233 platform (Illumina), paired-end reads at 75 cycles, and 80M reads/sample; reads were aligned to 234 reference human genome (hg19) and transcripts per kilobase million (TPM) were used as proxy 235 for gene expression level 2 . We excluded genes with low expression levels (mean TPM < 1) and 236 genes whose transcription start site (TSS) was unavailable in hg19. TPM values were 237 transformed to log 2 (TPM+1) for data analysis. 238 239 eQTM analysis 240
We focused on identifying cis-eQTMs (i.e., CpGs regulating transcription of neighboring genes), 241 due to limited power to perform a trans analysis (i.e., CpGs regulating distant genes) 23 . Thus, we 242 only considered methylation probes within 1 Mb from the TSS of a gene. Using this criterion, we 243 tested 8,552,964 methylation-gene expression pairs in analyses with and without adjustment for 244 covariates. The unadjusted analysis was conducted to filter out potential false positive signals 245 due to adjustment for batch effects 24, 25 . Of the 24,171 methylation-expression pairs with a false-246 discovery rate-adjusted P <0.01 (FDR-P, see below) in the adjusted analysis, 7,304 pairs had an 247 FDR-P ≥ 0.01 in the unadjusted analysis and were thus excluded from further consideration. Thus, 248 we identified 16,867 methylation-expression pairs that were significant in both unadjusted and 249 adjusted analyses. 250
251
For the adjusted analysis, we fitted a multivariate linear regression model; 
Mediation analysis 283
To understand how methylation affects asthma through gene expression as a putative mediator, 284 we conducted mediation analyses to identify indirectly associated methylation CpGs to atopic 285 asthma through gene expression. We used the Baron and Kenny approach 28 instead of the Sobel 286 method 29 , due to differences in sample size between the eQTM analysis (including all subjects) 287 and that for atopic asthma (including only subjects with atopic asthma and non-atopic controls). 288
289
To have a significant mediation of gene expression, all of the following needed to be significant: 290
1) the association between methylation and gene expression 2) the association between 291 methylation and atopic asthma 3) the association between gene expression and atopic asthma. 292
For #1, we only considered eQTM methylation probes and genes as candidates for the mediation 293 tests. For #2, we recalculated FDR-P values of the result from our prior EWAS 2 only for the 294 eQTM probes, to reduce multiple testing. For #3, we conducted a TWAS fitting a logistic 295 A chi-square test was conducted to examine the association between the region (whether the probe is located in the gene or outside of the gene) and the sign of the correlation. Enrichment of eQTM methylation probes in epigenome-wide association studies (EWAS) of atopic asthma (genome-wide FDR-P < 0.01). eQTM refers to eQTM probes and control refers to the same number of randomly selected probes. b. Enrichment of eQTM genes in differentially expressed genes (DEG) in atopic asthma. DEG were identified in our previous study of EVA-PR (genome-wide FDR < 0.01) 11 . eQTM refers to eQTM genes and control refers to the same number of randomly selected genes. c. A majority (89.4%) of the associations between eQTM probes and atopic asthma are mediated by gene expression. d. A majority of (98.3%) of the genes associated with asthma mediate the association between methylation and atopic asthma. The eQTM analysis was conducted in nasal airway epithelium, and the enhancer regions and their target genes were identified in lung tissue (http://www.enhanceratlas.org) 20 . A total of 81 eQTM CpGs that are located in enhancer regions of their target genes were found. a TSS is the transcription start site of the gene. c  g  2  0  3  7  2  7  5  9  1  2  5  8  1  6  2  2  8  7  1 . Probes sorted by EWAS p-value. Genes shown in bold are the nearest gene. 6  c  g  2  5  7  3  5  2  9  4  1  8  6  3  5  3  7  2  1  1  .  1  x  1  0   -2  0   C  2  0  o  r  f  1  9  7   2  0  3  .  8  x  1  0   -1  9   2  c  g  1  6  5  1  8  1  4  2  5  8  5  3  3  7  1  3  3 . 9 x 1 0 Significance for both differential expression and differential methylation defined as FDR-P<0.01. Genes shown sorted by TWAS p-value. Only the most significantly associated probe per gene is presented. T  W  A  S  p  -v  a  l  u  e   2  0  c  g  1  4  9  2  8  7  6  4  2  3  0  6  4  6  0  8   C  S  T  1   2  3  7  3  1  5  7  4  5 . Results sorted by TWAS p-value 11 . Total of 5394 mediation paths were identified. Only one mediation path was presented per gene. Mediation analysis was conducted using Baron and Kenny (1986) . Replication defined as FDR P<0.05 with effect in the same direction as in EVA-PR. Replication defined as FDR P<0.05 with effect in the same direction as in EVA-PR. Only one gene per methylation probe presented.
